Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment

被引：96

作者：

Kudo, Masatoshi ^{[1
]}

Trevisani, Franco ^{[2
]}

Abou-Alfa, Ghassan K. ^{[3
,4
]}

Rimassa, Lorenza ^{[5
]}

机构：

[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 377-2 Ohno Higashi, Osaka 5898511, Japan

[2] Univ Bologna, Alma Mater Studiorum, Dept Med & Surg Sci, Semeiot Unit, Bologna, Italy

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[4] Weill Cornell Med Coll, New York, NY USA

[5] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Med Oncol & Hematol Unit, Milan, Italy

来源：

LIVER CANCER | 2017年 / 6卷 / 01期

关键词：

Hepatocellular carcinoma; Practice guideline; Treatment; Treatment algorithm; CLINICAL-PRACTICE GUIDELINES; SURGICAL RESECTION; 2ND-LINE TREATMENT; ADULT PATIENTS; SORAFENIB; TIVANTINIB; ABLATION; MANAGEMENT; TRIAL; ACTIVATION;

D O I：

10.1159/000449343

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Western and Eastern perspectives on therapeutic guidelines for hepatocellular carcinoma (HCC) have many commonalities but may also differ in certain aspects, as described in this article. In view of the limited therapeutic options for advanced HCC, evidence-based therapies are few, and thus there is a dependence on consensus-based guidelines. This article focuses on the Italian Association for the Study of the Liver guidelines and the Japanese approaches to therapy, while drawing attention to certain controversies from other academic bodies where applicable and appropriate. Copyright (C) 2016 S. Karger AG, Basel

引用

页码：16 / 26

页数：11

共 40 条

[1] Phase II study of sorafenib in patients with advanced hepatocellular carcinoma [J].

Abou-Alfa, Ghassan K. ;

Schwartz, Lawrence ;

Ricci, Sergio ;

Amadori, Dino ;

Santoro, Armando ;

Figer, Arie ;

De Greve, Jacques ;

Douillard, Jean-Yves ;

Lathia, Chetan ;

Schwartz, Brian ;

Taylor, Ian ;

Moscovici, Marius ;

Saltz, Leonard B. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) :4293-4300

[2]

Abou-Alfa Ghassan K, 2011, Gastrointest Cancer Res, V4, P40

[3] Selection of Patients with Hepatocellular Carcinoma for Sorafenib [J].

Abou-Alfa, Ghassan K. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (04) :397-403

[4]

[Anonymous], J CLIN ONCOL S

[5] Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma [J].

Bolondi, Luigi ;

Cillo, Umberto ;

Colombo, Massimo ;

Craxi, Antonio ;

Farinati, Fabio ;

Giannini, Edoardo G. ;

Golfieri, Rita ;

Levrero, Massimo ;

Pinna, Antonio Daniele ;

Piscaglia, Fabio ;

Raimondo, Giovanni ;

Trevisani, Franco ;

Bruno, Raffaele ;

Caraceni, Paolo ;

Ciancio, Alessia ;

Coco, Barbara ;

Fraquelli, Mirella ;

Rendina, Maria ;

Squadrito, Giovanni ;

Toniutto, Pierluigi .

DIGESTIVE AND LIVER DISEASE, 2013, 45 (09) :712-723

[6]

Bruix J., 2016, WORLD GI ONC C BARC

[7] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial [J].

Bruix, Jordi ;

Raoul, Jean-Luc ;

Sherman, Morris ;

Mazzaferro, Vincenzo ;

Bolondi, Luigi ;

Craxi, Antonio ;

Galle, Peter R. ;

Santoro, Armando ;

Beaugrand, Michel ;

Sangiovanni, Angelo ;

Porta, Camillo ;

Gerken, Guido ;

Marrero, Jorge A. ;

Nadel, Andrea ;

Shan, Michael ;

Moscovici, Marius ;

Voliotis, Dimitris ;

Llovet, Josep M. .

JOURNAL OF HEPATOLOGY, 2012, 57 (04) :821-829

[8] Management of Hepatocellular Carcinoma: An Update [J].

Bruix, Jordi ;

Sherman, Morris .

HEPATOLOGY, 2011, 53 (03) :1020-1022

[9] A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J].

Chen, MS ;

Li, JQ ;

Zheng, Y ;

Guo, RP ;

Liang, HH ;

Zhang, YQ ;

Lin, XJ ;

Lau, WY .

ANNALS OF SURGERY, 2006, 243 (03) :321-328

[10] Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial [J].

Cheng, Ann-Lii ;

Kang, Yoon-Koo ;

Lin, Deng-Yn ;

Park, Joong-Won ;

Kudo, Masatoshi ;

Qin, Shukui ;

Chung, Hyun-Cheol ;

Song, Xiangqun ;

Xu, Jianming ;

Poggi, Guido ;

Omata, Masao ;

Lowenthal, Susan Pitman ;

Lanzalone, Silvana ;

Yang, Liqiang ;

Lechuga, Maria Jose ;

Raymond, Eric .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) :4067-+

← 1 2 3 4 →